Skorpios Trust
In its 13F for Q3 2025 (holdings as of September 30, 2025, filed October 29, 2025), Skorpios Trust reported 2 stock positions worth $53.2 million. Its top holding was Stoke Therapeutics (STOK) at 99.7% of the portfolio, followed by SS SPDR S&P Biotech ETF (XBI, 0.3%). Compared with Q2 2025, it reduced 1. The biggest sale was Stoke Therapeutics (STOK, shares −31%).
- Most Recent 13F
- Q3 2025
- Location
- LIMASSOL, G4
- CIK
- 0001869333
- Portfolio Value
- $53.2M (Q3 2025)
- SEC Filing
- 0001123292-25-000594 ↗ filed Oct 29, 2025
Holdings Value
Holdings 2 stocks · $53.2M
Portfolio Sells Q2 2025 → Q3 2025
| STOK Stoke Therapeutics Inc. | Reduce -30.7% | 99.68% | +0.06 |
Portfolio Buys Q2 2025 → Q3 2025
| None this quarter. | |||